Infectious Disease and Molecular Diagnostics Conference|Millennium Gloucester Hotel, London|21st – 22nd March 2024


Posted January 28, 2024 by SonalSen975

Infectious Disease and Molecular Diagnostics Conference 2024

 
We are pleased to announce the 5th Annual Infectious Disease Diagnostics and Molecular Diagnostics Conference, organized by MarketsandMarkets. This esteemed event is scheduled to take place on the 21st and 22nd of March 2024 in London. The conference has been handcrafted to showcase the latest insights in diagnostics, explore emerging technologies and their applications, address challenges within the diagnostics domain, including diagnostic settings, sample processing, regulations, validations, high costs of advanced technologies, challenges related to blood transfusion technology, and the global need for improved healthcare. It will also delve into topics such as vaccine efficacy, side effects, issues with test kits, and the importance of result accuracy.

Enquire Now @ https://events.marketsandmarkets.com/5th-annual-infectious-diseases-and-molecular-diagnostics-conference/

Implementing advanced technologies in the world of diagnostics.
The healthcare sector is undergoing significant transformations, largely due to advancements in technology, and the Diagnostics field has emerged as a pivotal catalyst in this evolution. Given its crucial role in treatment decisions, diagnostics must strive for speed, precision, and accuracy.

Key Highlights:-

Key Sessions on Molecular Diagnostics:


• Developing a Molecular and Rapid Testing Diagnostic Service
• The Impact of NGS in Diagnostic Virology Involving HIV-1 Tropism, Genotypic Resistance in Influenza, HBV, Hepatitis C Virus (HCV) and Cytomegalovirus (CMV)
• Current Molecular Diagnostics and Whole Genome Sequencing (WGS) Applied to Mycobacteria
• KCL TEST: Matching Results from the ONS and Generating Molecular Biology Laboratory-Based Protocols
• Molecular Diagnosis of Drug-Resistant Tuberculosis

Key Sessions on Infectious Diseases:


• Clinical Validation of a Point-of-Care Multiplexed In Vitro Immunoassay Using Monoclonal Antibodies
• The Impact of Digital Technologies on Point-of-Care Diagnostics in Resource-Limited Settings.
• The Challenges and Some Emerging Strategies for Tackling a Global Bacterial Menace
• Biosensors for the Detection of Bacterial and Viral Clinical Pathogens
• Electrochemical Diagnostics of Infectious Viral Diseases
-- END ---
Share Facebook Twitter
Print Friendly and PDF DisclaimerReport Abuse
Contact Email [email protected]
Issued By marketsandmarkets
Country India
Categories Business , Health , Marketing
Tags infectious disease and molecular diagnostics conference , infectious disease and molecular diagnostics , infectious disease and molecular , infectious disease , molecular diagnostics
Last Updated January 28, 2024